CIK 0001599298 · Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 371979717
- Phone
- 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | Clark Kenneth A Director | Grant or award · Stock Option (right to buy) | +44,400 | $1.67 | $74K | 79,400 |
| 2023-01-03 | Soni Manmeet Singh Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2023-01-03 | Booth Robert F. Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2023-01-03 | Booth Robert F. Director | Grant or award · Stock Option (right to buy) | +32,700 | $1.67 | $55K | 67,700 |
| 2022-12-06 | Zanganeh Mahkam Co-CEO & President | Other acquisition | +373,857 | 10,930,849 | ||
| 2022-12-06 | DUGGAN ROBERT W Chief Executive Officer | Other acquisition | +9,346,434 | 171,879,226 | ||
| 2022-11-15 | Cesano Alessandra Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2022-11-15 | Cesano Alessandra Director | Grant or award · Stock Option (right to buy) | +4,166 | 204,166 | ||
| 2022-09-28 | Booth Robert F. Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2022-09-28 | Booth Robert F. Director | Grant or award · Stock Option (right to buy) | +6,250 | 206,250 | ||
| 2022-08-16 | Dhingra Ankur Chief Financial Officer | Purchase | +13,027 | $0.97 | $13K | 39,527 |
| 2022-08-16 | Dhingra Ankur Chief Financial Officer | Purchase | +24,658 | $0.97 | $24K | 38,196 |
| 2022-08-16 | DUGGAN ROBERT W Chief Executive Officer | Purchase | +94,849,203 | $0.97 | $92.0M | 162,532,792 |
| 2022-08-16 | Zanganeh Maky Co-CEO & President | Purchase | +184,430 | $0.97 | $179K | 359,969 |
| 2022-08-16 | Zanganeh Maky Co-CEO & President | Purchase | +4,593,777 | $0.97 | $4.5M | 7,061,557 |
| 2022-08-16 | Zanganeh Maky Co-CEO & President | Purchase | +1,030,925 | $0.97 | $1000K | 3,135,466 |
| 2022-08-16 | Dhingra Ankur Chief Financial Officer | Purchase | +11,557 | $0.97 | $11K | 38,057 |
| 2022-08-16 | Dhingra Ankur Chief Financial Officer | Purchase | +24,658 | $0.97 | $24K | 38,196 |
| 2022-05-31 | Dhingra Ankur Chief Financial Officer | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2022-05-23 | DUGGAN ROBERT W Chief Executive Officer | Other acquisition | +21,135 | 67,683,589 |
Page 7 of 9 · 163 trades